News
ADGM
0.5610
-3.28%
-0.0190
Weekly Report: what happened at ADGM last week (0831-0904)?
Weekly Report · 5d ago
Weekly Report: what happened at ADGM last week (0824-0828)?
Weekly Report · 08/31 09:45
Weekly Report: what happened at ADGM last week (0817-0821)?
Weekly Report · 08/24 09:46
Weekly Report: what happened at ADGM last week (0810-0814)?
Weekly Report · 08/17 09:46
Adagio Medical Receives Nasdaq Listing Deficiency Notice
TipRanks · 08/14 21:14
Adagio Medical Highlights VT Ablation Progress in Presentation
TipRanks · 08/13 21:20
Adagio Medical Holdings Q2 EPS $(0.30) Beats $(0.31) Estimate
Benzinga · 08/11 12:34
*Adagio Medical 2Q Research and Development Expenses $2.5M >ADGM
Dow Jones · 08/11 12:31
*Adagio Medical 2Q Loss/Shr 30c >ADGM
Dow Jones · 08/11 12:31
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 08/11 12:06
Weekly Report: what happened at ADGM last week (0803-0807)?
Weekly Report · 08/10 09:43
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 08/05 12:05
Why Arista Networks Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
Benzinga · 08/05 08:57
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 08/04 21:06
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 08/04 17:05
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 08/04 12:05
Why Palantir Shares Are Trading Higher By 16%; Here Are 20 Stocks Moving Premarket
Benzinga · 08/04 08:42
Adagio Medical Stock Is Trending Overnight: Here's Why ADGM Jumped 22% After Hours
Benzinga · 08/04 05:58
Adagio Medical Treats First Patient With Next-Generation VCLAS Ultra System; Stock Up
NASDAQ · 08/04 04:23
Adagio Medical treats first patient with vCLAS Ultra ULTA system
TipRanks · 08/03 12:46
More
Webull provides a variety of real-time ADGM stock news. You can receive the latest news about Adagio Medical through multiple platforms. This information may help you make smarter investment decisions.
About ADGM
Adagio Medical Holdings, Inc. is a medical device company. The Company is focused on developing and commercializing products for the treatment of cardiac arrhythmias with catheter-based ultra-low temperature ablation (ULTA) technology, formerly known as ultra-low temperature cryoablation (ULTC) technology. Its initial focus is on the treatment of ventricular tachycardia (VT), which is a rapid, abnormal heart rhythm, or arrhythmia, that originates in the heart’s lower chambers, or ventricles, potentially leading to impaired blood flow and, if sustained, it can be fatal. Its ULTA products are purpose-built to treat patients with VT and are designed to address the unique anatomy of the ventricle and the specific needs of the VT patient. Its catheters and consoles are designed to create titratable, large, durable, deep lesions within the ventricle through a stable, endocardial or inside the heart approach with no required irrigation.